Unipolar Depression Clinical Trial
Official title:
Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Psychiatric-psychotherapeutic Care: Randomized Controlled Trial
Aim of the current study is to investigate the acceptance and efficacy of Metacognitive Training for Depression (D-MCT) compared to cognitive remediation in outpatients with major depressive disorders in a randomized, controlled, assessor-blind, group trial.
Evidence-based treatments for depression include pharmacological and psychological
interventions. Within psychological interventions, cognitive behavioral therapy (CBT) is one
of the most extensively researched evidence-based approaches for depression (Cuijpers, 2015).
However, even if optimal treatment and access to services were available to all patients, the
burden of depression would be reduced by only 30% (Andrews et al., 2004). Moreover, as
depression represents the disorder with the highest drop-out rates during CBT treatment
(36.4%) (Fernandez et al., 2015), and a relapse rate of 54% for treatment responders within
the two years after treatment termination (Vittengl et al., 2007), it is pivotal to improve
treatment for depression. It has been argued that this is less a question of developing novel
psychological treatments as of determining how existing treatments may be improved (Cuijpers,
2015) and better disseminated to increase retention rates and to use the waiting phase to
rise interest in therapy (Fernandez et al., 2015). Due to hopelessness and the discouraging
character of the disorder, this poses a particular challenge.
To meet this aim, Metacognitive Training for Depression (D-MCT) has been developed as a
low-threshold, highly standardized and yet easy to administer group concept for the treatment
of depression. It is conceptualized as a variant of CBT that adopts a metacognitive
perspective focusing on the modification of cognitive biases, and is compatible with a
general CBT treatment approach. Use of standardized presentations reduces time needed for
preparation and administration of the training; moreover, this "packaging" increases the
accessibility of D-MCT to a wide range of health care providers, and encourages
standardization across therapists. The training seeks to enable group members to recognize
and correct the often automatic and unconscious thought patterns that accompany depression.
To this end, it attempts to challenge cognitive biases through the use of creative and
engaging exercises supported by a multimedia presentation (e.g., insight based on "aha"
effects rather than psychoeducation) and to encourage patients to take a metacognitive
perspective ("think about one's thinking"). The training is highly flexible with regard to
depth and intensity. Patients do not need to (but may) discuss their own problems, and can
still experience how cognitive biases work and influence one's mood in a playful atmosphere.
The training is conceptualized as an open group: New patients can join the group in every
session. Thus, the threshold for administration of and participation in this intervention is
low.
The general structure of and exercises in D-MCT were inspired by Metacognitive Training for
psychosis (Moritz et al., 2014); however, contents were modified upon to suit the specific
problems of individuals with depression. Beside depressive thought patterns already targeted
in CBT (e.g., overgeneralization, "mind reading"), a number of general cognitive biases,
which have been identified by basic cognitive research, form the core of D-MCT (e.g.,
mood-congruent memory (Mathews and MacLeod, 2005)). Finally, as in Metacognitive Therapy
(MCT) sensu Adrian Wells (Wells, 2011) dysfunctional coping strategies (i.e., thought
suppression, rumination as problem-solving) are challenged. D-MCT thus blends established
elements from CBT and MCT as well as newly developed and evidence-based exercises in one
coherent metacognitive approach.
D-MCT was positively evaluated with regard to feasibility and acceptance in a non-randomized
pilot study (Jelinek et al., 2013). Moreover, efficacy of D-MCT was suggested in a randomized
controlled trail (RCT) in comparison to an active control intervention (Jelinek et al.,
2016). In this trial patients with depressive disorder were completing a psychosomatic
outpatient treatment program and were randomly assigned to either D-MCT or general health
training. Severity of depression and cognitive biases were assessed at baseline (t0), post
treatment (t1) and 6 months (t2) later by raters blind to diagnostic status.
Intention-to-treat analyses demonstrated that at the end of treatment, as well as 6 months
later, improvement in depression was significantly greater in the D-MCT relative to the
health training group at medium effect sizes. A significantly greater number of patients in
the D-MCT group were in remission at 6-month follow-up. Moreover, the decrease in cognitive
biases and increase in psychological well-being/quality of life was larger in the D-MCT than
the health training group over time. Patients' subjective appraisal of D-MCT was also
positive (Jelinek et al., 2017).
Aim of the current study is to investigate the acceptance and efficacy of D-MCT in
outpatients.The Hamilton Depression Rating Scale (HDRS, 17-item version) total score as well
as the Quick Inventory of Depressive Symptomatology (QIDS) serve as primary outcome.
Self-assessed depression, dysfunctional beliefs, self-esteem, quality of life, rumination,
remission rate as well as neuropsychological functioning serve as secondary outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03256162 -
Ketamine as an Adjunctive Therapy for Major Depression
|
Phase 1 | |
Recruiting |
NCT05570110 -
Enoxolone in Major Depression - Biomarker-outcome Relationship
|
Phase 1/Phase 2 | |
Completed |
NCT02530164 -
Transcranial Direct Current Stimulation (tDCS) As Treatment for Major Depression
|
N/A | |
Completed |
NCT00964054 -
Depression Outcomes Study of Exercise
|
Phase 1 | |
Completed |
NCT01447602 -
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
|
Phase 3 | |
Completed |
NCT00517387 -
The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression
|
Phase 3 | |
Recruiting |
NCT04939649 -
Ketamine as an Adjunctive Therapy for Major Depression (2)
|
Phase 3 | |
Recruiting |
NCT05894980 -
How to Reduce Suicidal Thoughts and Impulsivity in Depression
|
N/A | |
Terminated |
NCT04712968 -
Efficacy of Daylight as Adjunctive Treatment in Patients With Depression
|
N/A | |
Enrolling by invitation |
NCT04717921 -
Assesment of Retinal Nerve Fiber Layer in First Episode Depressive Patients Using Selective Serotonin Reuptake Inhibitor
|
||
Recruiting |
NCT03358056 -
Effects of Mindfulness Based Cognitive Therapy on Emotional Processing
|
N/A | |
Recruiting |
NCT03711019 -
Efficacy of Convulsive Therapies During Continuation
|
N/A | |
Completed |
NCT02104232 -
Thinking Healthy Program - Peer Delivered, India (THPP-I)
|
N/A | |
Completed |
NCT02111915 -
Thinking Healthy Program - Peer Delivered (Pakistan)
|
N/A | |
Terminated |
NCT01219686 -
EScitalopram PIndolol ONset of Action
|
Phase 2/Phase 3 | |
Completed |
NCT00158990 -
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
|
Phase 3 | |
Completed |
NCT01049347 -
Amitriptyline and Paroxetine Treatment of Major Depression
|
Phase 3 | |
Completed |
NCT01880957 -
PET and MRI Brain Imaging of Bipolar Disorder
|
N/A | |
Completed |
NCT04420793 -
Voice Changes During ECT
|
||
Not yet recruiting |
NCT01694030 -
Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical Study
|
Phase 1 |